PCRX vs IRWD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PCRX

48.2
AI Score
VS
IRWD Wins

IRWD

53.4
AI Score

Investment Advisor Scores

PCRX

48score
Recommendation
HOLD

IRWD

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCRX IRWD Winner
Revenue 369.77M 219.55M PCRX
Net Income 7.57M 92.06M IRWD
Net Margin 2.0% 41.9% IRWD
Operating Income 11.17M 151.88M IRWD
ROE 1.1% -56.9% PCRX
ROA 0.6% 32.3% IRWD
Total Assets 1.24B 285.13M PCRX
Cash 205.88M 79.13M PCRX
Current Ratio 5.04 6.06 IRWD

Relative Price Performance (Last 90 Days)

PCRX 1M: +7.0% · 3M: +8.6% IRWD 1M: -5.6% · 3M: +12.4%

Current Technical Phase

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $25.36

IRWD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.9 · Price: $4.08

Fundamentals Snapshot

Metric PCRX IRWD
Market Cap
Forward P/E 7.4 2.7
Trailing P/E 74.0 5.2
Revenue (TTM)
Revenue Growth 0.1% 0.3%
Gross Margin 0.8% 0.8%
Operating Margin 0.1% 0.7%
EPS 0.34 0.77
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IRWD is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.